Skin necrosis following Haemaccel.
Haemaccel is a plasma substitute in frequent clinical use with a low incidence of side effects. I report a patient who developed necrotic blisters following two Haemaccel-insulin infusions, a previously undescribed complication. The rationale behind carrier solutions for insulin therapy is discussed and some of the problems associated with Haemaccel use are considered. I conclude by urging caution in the use of Haemaccel as a carrier solution for insulin therapy.
D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D011097:Polygeline / Q000009:adverse effects*; D011108:Polymers / Q000009:adverse effects*; D012867:Skin / Q000473:pathology*
D011108:Polymers; D011097:Polygeline